price

NASDAQ · BCRX
BioCryst Pharmaceuticals, Inc.
Healthcare · Biotechnology
$7.79
Down-$0.23 (-2.87%)
Updated Oct 18, 2026, 9:12 PM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.6B
- P/E ratio
- -181.47
- Dividend yield
- 0.00%
- 52-week range
- $7.74 – $11.22
- Volume
- 4.43M
- Avg. volume
- 4.95M
Price performance · BCRX
BCRX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 16, 2026
BCRX closed at $7.79 after 20 trading sessions, down 11.07% for the selected period.
- Last close
- $7.79
- Period change
- -11.07%
- Period low
- $7.79
- Period high
- $8.78
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | $7.96 | $8.015 | $7.74 | $7.79 | 4.43M |
| Oct 15, 2026 | $8.105 | $8.24 | $7.945 | $8.02 | 4.5M |
| Oct 14, 2026 | $8.02 | $8.18 | $7.97 | $8.05 | 5.65M |
| Oct 13, 2026 | $8.22 | $8.315 | $8.06 | $8.07 | 3.04M |
| Oct 12, 2026 | $8.49 | $8.55 | $8.24 | $8.36 | 3.47M |
| Oct 9, 2026 | $8.27 | $8.595 | $8.27 | $8.55 | 2.31M |
| Oct 8, 2026 | $8.36 | $8.40 | $8.13 | $8.29 | 5.12M |
| Oct 7, 2026 | $7.91 | $8.425 | $7.86 | $8.40 | 5.12M |
| Oct 6, 2026 | $8.15 | $8.15 | $7.87 | $7.95 | 3.94M |
| Oct 5, 2026 | $8.17 | $8.25 | $7.915 | $8.10 | 4.71M |
| Oct 2, 2026 | $8.12 | $8.20 | $7.92 | $8.17 | 6.15M |
| Oct 1, 2026 | $8.30 | $8.38 | $8.065 | $8.12 | 6.87M |
| Sep 30, 2026 | $8.28 | $8.42 | $8.1841 | $8.33 | 13.1M |
| Sep 29, 2026 | $8.42 | $8.50 | $8.22 | $8.27 | 5.01M |
| Sep 28, 2026 | $8.555 | $8.66 | $8.335 | $8.47 | 4.35M |
| Sep 25, 2026 | $8.52 | $8.63 | $8.40 | $8.59 | 3.67M |
| Sep 24, 2026 | $8.535 | $8.65 | $8.395 | $8.52 | 4.85M |
| Sep 23, 2026 | $8.75 | $8.86 | $8.455 | $8.57 | 4.47M |
| Sep 22, 2026 | $8.87 | $9.035 | $8.72 | $8.78 | 3.44M |
| Sep 21, 2026 | $8.75 | $8.845 | $8.575 | $8.76 | 3.46M |
Latest BCRX news
The latest Smart Investors Daily articles mentioning BCRX.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…

